Nanosphere Health Sciences Inc
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more
Nanosphere Health Sciences Inc (NSHSF) - Total Assets
Latest total assets as of September 2025: $16.23K USD
Based on the latest financial reports, Nanosphere Health Sciences Inc (NSHSF) holds total assets worth $16.23K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nanosphere Health Sciences Inc - Total Assets Trend (2005–2024)
This chart illustrates how Nanosphere Health Sciences Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nanosphere Health Sciences Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Nanosphere Health Sciences Inc's total assets of $16.23K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.9% |
| Accounts Receivable | $11.56K | 85.1% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2005–2024)
This chart illustrates how Nanosphere Health Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanosphere Health Sciences Inc's current assets represent 100.0% of total assets in 2024, unchanged from 100.0% in 2005.
- Cash Position: Cash and equivalents constituted 14.9% of total assets in 2024, down from 99.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 85.1% of total assets.
Nanosphere Health Sciences Inc Competitors by Total Assets
Key competitors of Nanosphere Health Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Nanosphere Health Sciences Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nanosphere Health Sciences Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Nanosphere Health Sciences Inc generates $ 1.94 in net profit.
Nanosphere Health Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.01 | 0.01 |
| Quick Ratio | 0.01 | 0.01 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.37 Million | $ -1.68 Million | $ -1.49 Million |
Nanosphere Health Sciences Inc - Advanced Valuation Insights
This section examines the relationship between Nanosphere Health Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.84 |
| Latest Market Cap to Assets Ratio | 29.12 |
| Asset Growth Rate (YoY) | -24.4% |
| Total Assets | $13.59K |
| Market Capitalization | $395.89K USD |
Valuation Analysis
Premium Asset Valuation: The market values Nanosphere Health Sciences Inc's assets at a significant premium ( 29.12x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Nanosphere Health Sciences Inc's assets decreased by 24.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nanosphere Health Sciences Inc (2005–2024)
The table below shows the annual total assets of Nanosphere Health Sciences Inc from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $13.59K | -24.36% |
| 2023-12-31 | $17.97K | -70.07% |
| 2022-12-31 | $60.05K | -54.68% |
| 2021-12-31 | $132.51K | +140.11% |
| 2020-12-31 | $55.19K | -83.46% |
| 2019-12-31 | $333.72K | -74.70% |
| 2018-12-31 | $1.32 Million | -65.72% |
| 2017-12-31 | $3.85 Million | +275.93% |
| 2016-12-31 | $1.02 Million | +463.77% |
| 2015-12-31 | $181.58K | +90.36% |
| 2014-12-31 | $95.39K | -0.51% |
| 2013-12-31 | $95.88K | -98.61% |
| 2012-12-31 | $6.88 Million | +12.21% |
| 2011-12-31 | $6.13 Million | +22.61% |
| 2010-12-31 | $5.00 Million | +891.13% |
| 2009-12-31 | $504.52K | +55.16% |
| 2008-12-31 | $325.15K | -95.82% |
| 2007-12-31 | $7.78 Million | +2564.40% |
| 2006-12-31 | $291.87K | -8.49% |
| 2005-12-31 | $318.94K | -- |